VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Dose-dense temozolomide regimens: antitumor activity, toxicity, and immunomodulatory effects.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Dose-dense temozolomide regimens: antitumor activity, toxicity, and immunomodulatory effects.
Dose-dense temozolomide regimens: antitumor activity, toxicity, and immunomodulatory effects. Cancer. 2010 Jun 15; 116(12):2868-77.
View in:
PubMed
subject areas
Antineoplastic Agents, Alkylating
Cancer Vaccines
Combined Modality Therapy
Dacarbazine
Drug Administration Schedule
Glioma
Humans
Immunologic Factors
Lymphopenia
Melanoma
Treatment Outcome
authors with profiles
WEN-JEN HWU